Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Other Working Capital Changes: 2020-2025

Historic Other Working Capital Changes for Xeris Biopharma Holdings (XERS) over the last 5 years, with Sep 2025 value amounting to $5.2 million.

  • Xeris Biopharma Holdings' Other Working Capital Changes rose 3424.52% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 55.55%. This contributed to the annual value of $1.7 million for FY2024, which is 77.81% down from last year.
  • According to the latest figures from Q3 2025, Xeris Biopharma Holdings' Other Working Capital Changes is $5.2 million, which was up 2,008.52% from -$270,000 recorded in Q2 2025.
  • Xeris Biopharma Holdings' Other Working Capital Changes' 5-year high stood at $5.2 million during Q3 2025, with a 5-year trough of -$3.7 million in Q4 2021.
  • In the last 3 years, Xeris Biopharma Holdings' Other Working Capital Changes had a median value of $684,000 in 2023 and averaged $1.1 million.
  • As far as peak fluctuations go, Xeris Biopharma Holdings' Other Working Capital Changes tumbled by 1,547.24% in 2021, and later skyrocketed by 3,424.52% in 2025.
  • Over the past 5 years, Xeris Biopharma Holdings' Other Working Capital Changes (Quarterly) stood at -$3.7 million in 2021, then spiked by 130.71% to $1.1 million in 2022, then declined by 20.90% to $893,000 in 2023, then plummeted by 71.89% to $251,000 in 2024, then skyrocketed by 3,424.52% to $5.2 million in 2025.
  • Its Other Working Capital Changes was $5.2 million in Q3 2025, compared to -$270,000 in Q2 2025 and -$1.5 million in Q1 2025.